Tiny 2ycnwtl vq srzjc33dio74b27eqmgh smgei6xqb5u

Katrine Bosley

CEO, Editas Medicine

Katrine Bosley is the CEO of Editas Medicine and has been in the biotechnology industry for over 20 years. She was recently the Entrepreneur-in-Residence at the Broad Institute and a review committee member for the Translation Fund at the Wellcome Trust. Prior to that, Katrine led Avila Therapeutics as its CEO (acquired by Celgene) and was VP, Business Development at Adnexus Therapeutics (acquired by BMS). Earlier, she held several positions at Biogen Idec in business development, commercial operations and portfolio strategy in the U.S. and Europe. Before that she was part of the healthcare team at the venture firm Highland Capital Partners and was an early employee of Alkermes.